{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:40:41Z","timestamp":1793050841075,"version":"4.5.0"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The global prevalence of osteopenia among people with chronic kidney disease (CKD) remains uncertain. This research aimed to estimate the global and regional prevalence of osteopenia in CKD patients. Databases including PubMed, Scopus, Science Direct, Web of Science, and Embase, along with Google Scholar engine, were explored from January 1, 2000, to January 1, 2025, in English. The eligibility criteria included adults (\u2265\u200918\u00a0years) with CKD stages 3a-5D. The risk of bias assessment performed using the Joanna Briggs Institute (JBI) checklist. The I-square index was employed to assess heterogeneity, whereas publication bias was evaluated through Egger\u2019s test and funnel plots. Statistical analyses were performed using Stata software Version 17. The prevalence of femoral neck osteopenia in CKDs estimated 47% (95% CI: 43 to 50,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200945). The lumbar spine osteopenia estimated 35% (95% CI: 33 to 37,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200952). Based on specific bone site, the osteopenia prevalence is 40% (95% CI: 35 to 45,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200924) in total hip, 28% (95% CI: 19 to 38,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20095) in forearm, and 31% (95% CI: 24 to 37,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20099) in distal radius. The sex-specific rate is 37% (95% CI: 32 to 42,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200930) for men and 36% (95% CI: 31 to 41,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200930) for women. Our study uncovered a significant prevalence of osteopenia in CKD patients stages 3a-5D, with the highest rate in bone areas abundant in cortical content (femoral neck region).\n                  <\/jats:p>","DOI":"10.1007\/s10238-025-01909-3","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:53:30Z","timestamp":1762844010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Global and regional prevalence of osteopenia in chronic kidney disease: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9240-494X","authenticated-orcid":false,"given":"Mobin","family":"Ghazaiean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2395-8118","authenticated-orcid":false,"given":"Iradj","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2505-370X","authenticated-orcid":false,"given":"Tahoora","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7788-5471","authenticated-orcid":false,"given":"Behnam","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5452-514X","authenticated-orcid":false,"given":"Mahmood","family":"Moosazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"1909_CR1","doi-asserted-by":"crossref","first-page":"1177829","DOI":"10.3389\/fphys.2023.1177829","volume":"14","author":"A Aguilar","year":"2023","unstructured":"Aguilar A, et al. Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis. Front Physiol. 2023;14:1177829.","journal-title":"Front Physiol"},{"issue":"3","key":"1909_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MNH.0000000000000411","volume":"27","author":"K Connelly","year":"2018","unstructured":"Connelly K, Collister D, Tangri N. Fracture risk and treatment in chronic kidney disease. Curr Opin Nephrol Hypertens. 2018;27(3):221\u20135.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1909_CR3","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s11914-018-0491-3","volume":"16","author":"P Khairallah","year":"2018","unstructured":"Khairallah P, Nickolas TL. Updates in CKD-associated osteoporosis. Curr Osteoporos Rep. 2018;16:712\u201323.","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"1909_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"K KDIGO","year":"2017","unstructured":"KDIGO K. Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1\u201359.","journal-title":"Kidney Int Suppl"},{"issue":"8","key":"1909_CR5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.34172\/aim.2021.85","volume":"24","author":"S Amirkhanlou","year":"2021","unstructured":"Amirkhanlou S, et al. Assessment of bone mineral density in patients undergoing hemodialysis; an Iranian population-based study. Arch Iran Med. 2021;24(8):599\u2013606.","journal-title":"Arch Iran Med"},{"issue":"5","key":"1909_CR6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.rxeng.2011.09.005","volume":"54","author":"RL Ramos","year":"2012","unstructured":"Ramos RL, et al. Dual energy X-ray absorptimetry: fundamentals, methodology, and clinical applications. Radiolog\u00eda (English Edition). 2012;54(5):410\u201323.","journal-title":"Radiolog\u00eda (English Edition)"},{"key":"1909_CR7","unstructured":"Krugh M, Langaker MD. Dual energy x-ray absorptiometry. 2018."},{"key":"1909_CR8","doi-asserted-by":"crossref","unstructured":"Khan AA et al. Osteoporotic fractures: diagnosis, evaluation, and significance from the International Working Group on DXA Best Practices. in Mayo clinic proceedings. Elsevier; 2024.","DOI":"10.1016\/j.mayocp.2024.01.011"},{"issue":"2","key":"1909_CR9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00259-024-06912-6","volume":"52","author":"RH Slart","year":"2025","unstructured":"Slart RH, et al. Updated practice guideline for dual-energy X-ray absorptiometry (DXA). Eur J Nucl Med Mol Imaging. 2025;52(2):539\u201363.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1909_CR10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"K Ja","year":"1994","unstructured":"Ja K. Perspective: the diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137\u201341.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"1909_CR11","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, et al. Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359\u201381.","journal-title":"Osteoporos Int"},{"issue":"9","key":"1909_CR12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4158\/EP161435.ESGL","volume":"22","author":"PM Camacho","year":"2016","unstructured":"Camacho PM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142016\u2013executive summary. Endocr Pract. 2016;22(9):1111\u20138.","journal-title":"Endocr Pract"},{"issue":"5","key":"1909_CR13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00198-019-04864-4","volume":"30","author":"K Bezerra de Carvalho","year":"2019","unstructured":"Bezerra de Carvalho K, et al. Chronic kidney disease is associated with low BMD at the hip but not at the spine. Osteoporosis Int. 2019;30(5):1015\u201323.","journal-title":"Osteoporosis Int"},{"issue":"11","key":"1909_CR14","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: improving global outcomes (KDIGO). Kidney Int. 2006;69(11):1945\u201353.","journal-title":"Kidney Int"},{"issue":"6","key":"1909_CR15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jbspin.2012.09.014","volume":"79","author":"F Mac Way","year":"2012","unstructured":"Mac Way F, Lessard M, Lafage-Proust M-H. Pathophysiology of chronic kidney disease-mineral and bone disorder. Joint Bone Spine. 2012;79(6):544\u20139.","journal-title":"Joint Bone Spine"},{"issue":"9684","key":"1909_CR16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145\u201358.","journal-title":"Lancet"},{"issue":"6","key":"1909_CR17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","volume":"70","author":"T Isakova","year":"2017","unstructured":"Isakova T, et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2017;70(6):737\u201351.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1909_CR18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00467-009-1337-0","volume":"25","author":"KA Hruska","year":"2010","unstructured":"Hruska KA, et al. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). Pediatr Nephrol. 2010;25(4):769\u201378.","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"1909_CR19","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/jbmr.4681","volume":"37","author":"C Jiang","year":"2020","unstructured":"Jiang C, Yan C, Duan J. Bone mineral density is inversely associated with mortality in chronic kidney disease patients: a meta-analysis. J Bone Miner Res. 2020;37(11):2094\u2013102.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1909_CR20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00198-022-06598-2","volume":"34","author":"MP Duarte","year":"2023","unstructured":"Duarte MP, et al. Prevalence of low bone mineral density (T-score\u2264\u2212 2.5) in the whole spectrum of chronic kidney disease: a systematic review and meta-analysis. Osteoporos Int. 2023;34(3):467\u201377.","journal-title":"Osteoporos Int"},{"issue":"11","key":"1909_CR21","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","volume":"17","author":"TL Nickolas","year":"2006","unstructured":"Nickolas TL, McMahon DJ, Shane E. Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol. 2006;17(11):3223\u201332.","journal-title":"J Am Soc Nephrol"},{"key":"1909_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00198-019-05190-5","volume":"31","author":"N Goto","year":"2020","unstructured":"Goto N, et al. The association between chronic kidney disease, falls, and fractures: a systematic review and meta-analysis. Osteoporos Int. 2020;31:13\u201329.","journal-title":"Osteoporos Int"},{"issue":"22","key":"1909_CR23","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1001\/jama.286.22.2815","volume":"286","author":"ES Siris","year":"2001","unstructured":"Siris ES, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286(22):2815\u201322.","journal-title":"JAMA"},{"issue":"11","key":"1909_CR24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S2213-8587(24)00225-0","volume":"12","author":"IR Reid","year":"2024","unstructured":"Reid IR, McClung MR. Osteopenia: a key target for fracture prevention. Lancet Diabetes Endocrinol. 2024;12(11):856\u201364.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1909_CR25","doi-asserted-by":"crossref","unstructured":"Page MJ et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. bmj. 2021;372.","DOI":"10.1136\/bmj.n71"},{"issue":"3","key":"1909_CR26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2023.101369","volume":"26","author":"JA Shepherd","year":"2023","unstructured":"Shepherd JA. Positions of the International Society for Clinical Densitometry and their etiology: a scoping review. J Clin Densitom. 2023;26(3):101369.","journal-title":"J Clin Densitom"},{"issue":"4","key":"1909_CR27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","volume":"22","author":"CR Shuhart","year":"2019","unstructured":"Shuhart CR, et al. Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom. 2019;22(4):453\u201371.","journal-title":"J Clin Densitom"},{"key":"1909_CR28","unstructured":"Baszko-Blaszyk D et al. Bone mass in chronic renal insufficiency patients treated with continuous ambulatory peritoneal dialysis. In: Advances in peritoneal dialysis. Conference on peritoneal dialysis, 2001."},{"issue":"4","key":"1909_CR29","first-page":"291","volume":"53","author":"Y Chen","year":"2000","unstructured":"Chen Y, et al. Body composition in hemodialysis patients\u2013is it different from that of normal subjects? Clin Nephrol. 2000;53(4):291\u20135.","journal-title":"Clin Nephrol"},{"issue":"4","key":"1909_CR30","first-page":"874","volume":"28","author":"PK Etta","year":"2017","unstructured":"Etta PK, Sharma R, Gupta A. Study of chronic kidney disease-mineral bone disorders in newly detected advanced renal failure patients: a hospital-based cross-sectional study. Saudi J Kidney Dis Transpl. 2017;28(4):874\u201385.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"3","key":"1909_CR31","first-page":"218","volume":"54","author":"M Fontaine","year":"2000","unstructured":"Fontaine M, et al. Fracture and bone mineral density in hemodialysis patients. Clin Nephrol. 2000;54(3):218\u201326.","journal-title":"Clin Nephrol"},{"issue":"6","key":"1909_CR32","first-page":"437","volume":"13","author":"A Gerakis","year":"2000","unstructured":"Gerakis A, et al. Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol. 2000;13(6):437\u201343.","journal-title":"J Nephrol"},{"key":"1909_CR33","unstructured":"Grzegorzewska AE, M\u0142ot-Michalska M. Low molecular weight heparins and antiplatelet drugs, and bone mineral density in dialysis patients. In: Advances in peritoneal dialysis. Conference on peritoneal dialysis, 2008."},{"key":"1909_CR34","unstructured":"Grzegorzewska AE, M\u0142ot-Michalska M. Bone mineral density, its predictors, and outcomes in peritoneal dialysis patients. in Advances in Peritoneal dialysis. In: Conference on peritoneal dialysis, 2011."},{"issue":"4","key":"1909_CR35","first-page":"1031","volume":"30","author":"A Hai","year":"2021","unstructured":"Hai A, et al. Status of serum calcium, phosphate and intact parathyroid hormone in predialysis chronic kidney disease patients of stage-3 to stage-5 compared to KDOQI guideline. Mymensingh Med J MMJ. 2021;30(4):1031\u201342.","journal-title":"Mymensingh Med J MMJ"},{"issue":"2","key":"1909_CR36","first-page":"103","volume":"32","author":"D Jain","year":"2019","unstructured":"Jain D, Aggarwal H, Chhabra P. Evaluation of bone mineral density in predialysis osteoporotic patients of chronic kidney disease. JIMSA. 2019;32(2):103.","journal-title":"JIMSA"},{"issue":"2","key":"1909_CR37","first-page":"28","volume":"42","author":"E Kumchev","year":"2000","unstructured":"Kumchev E, et al. Influence of age, sex and body weight on renal osteodystrophy in predialysis patients with chronic renal failure. Folia Med. 2000;42(2):28\u201333.","journal-title":"Folia Med"},{"issue":"12","key":"1909_CR38","first-page":"845","volume":"34","author":"LB Lasic","year":"2005","unstructured":"Lasic LB, DeVita MV, Michelis MF. Coronary artery calcifications and bone pathology in hemodialysis patients with low PTH levels. Dial Transplant. 2005;34(12):845\u201350.","journal-title":"Dial Transplant"},{"issue":"11","key":"1909_CR39","first-page":"733","volume":"29","author":"CT LEE","year":"2000","unstructured":"LEE CT, et al. Increased bone mineral density after desferrioxamine treatment in chronic hemodialysis patients with aluminum bone disease. Dial Transp. 2000;29(11):733\u201352.","journal-title":"Dial Transp"},{"issue":"11","key":"1909_CR40","first-page":"788","volume":"31","author":"T Nakai","year":"2002","unstructured":"Nakai T, Masuhara K, Kanbara N. Bone mineral density decrease is associated with alkaline phosphatase and carboxy-terminal parathyroid hormone in hemodialysis patients. Dial Transplant. 2002;31(11):788\u201391.","journal-title":"Dial Transplant"},{"issue":"5","key":"1909_CR41","first-page":"373","volume":"59","author":"N Takahashi","year":"2003","unstructured":"Takahashi N, et al. Long-term evaluation of nutritional status using dual-energy X-ray absorptiometry in chronic hemodialysis patients. Clin Nephrol. 2003;59(5):373\u20138.","journal-title":"Clin Nephrol"},{"issue":"2","key":"1909_CR42","first-page":"253","volume":"17","author":"C Zoccali","year":"2004","unstructured":"Zoccali C, et al. Leptin and biochemical markers of bone turnover in dialysis patients. J Nephrol. 2004;17(2):253\u201360.","journal-title":"J Nephrol"},{"issue":"3","key":"1909_CR43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s11205-023-03230-6","volume":"170","author":"S Morse","year":"2023","unstructured":"Morse S. Quality of life, well-being and the human development index: a media narrative for the developed world? Soc Indic Res. 2023;170(3):1035\u201358.","journal-title":"Soc Indic Res"},{"issue":"3","key":"1909_CR44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0921-8009(97)00168-7","volume":"25","author":"AD Sagar","year":"1998","unstructured":"Sagar AD, Najam A. The human development index: a critical review. Ecol Econ. 1998;25(3):249\u201364.","journal-title":"Ecol Econ"},{"issue":"3","key":"1909_CR45","first-page":"147","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, et al. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. JBI Evid Implement. 2015;13(3):147\u201353.","journal-title":"JBI Evid Implement"},{"key":"1909_CR46","unstructured":"Higgins Jpt T et al. Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane, 2022."},{"issue":"6","key":"1909_CR47","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Med Res. 2018;27(6):1785\u2013805.","journal-title":"Stat Med Res"},{"key":"1909_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-1","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, et al. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:1\u201313.","journal-title":"BMC Med Res Methodol"},{"key":"1909_CR49","doi-asserted-by":"crossref","unstructured":"Fisher DJ et al. Meta\u2010analysis in stata. In: Systematic reviews in health research: meta\u2010analysis in context, 2022. p. 481\u2013509.","DOI":"10.1002\/9781119099369.ch25"},{"issue":"9","key":"1909_CR50","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/nu14091742","volume":"14","author":"M Fusaro","year":"2022","unstructured":"Fusaro M, et al. Time for revival of bone biopsy with histomorphometric analysis in chronic kidney disease (CKD): moving from skepticism to pragmatism. Nutrients. 2022;14(9):1742.","journal-title":"Nutrients"},{"issue":"4","key":"1909_CR51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jocd.2013.08.004","volume":"16","author":"JT Schousboe","year":"2013","unstructured":"Schousboe JT, et al. Executive summary of the 2013 International Society for Clinical Densitometry position development conference on bone densitometry. J Clin Densitom. 2013;16(4):455\u201366.","journal-title":"J Clin Densitom"},{"issue":"2","key":"1909_CR52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1385\/JCD:6:2:75","volume":"6","author":"CV Albanese","year":"2003","unstructured":"Albanese CV, Diessel E, Genant HK. Clinical applications of body composition measurements using DXA. J Clin Densitom. 2003;6(2):75\u201385.","journal-title":"J Clin Densitom"},{"key":"1909_CR53","unstructured":"Dual Energy X. ray absorptiometry for bone mineral density and body composition assessment in: IAEA human health series No. 15. International Atomic Energy Agency (IAEA); Vienna, 2010."},{"issue":"3","key":"1909_CR54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1385\/JCD:6:3:199","volume":"6","author":"N Binkley","year":"2003","unstructured":"Binkley N, Krueger D, Vallarta-Ast N. An overlying fat panniculus affects femur bone mass measurement. J Clin Densitom. 2003;6(3):199\u2013204.","journal-title":"J Clin Densitom"},{"issue":"3","key":"1909_CR55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2967\/jnmt.122.264885","volume":"51","author":"KP Banks","year":"2023","unstructured":"Banks KP, et al. Improving DXA quality by avoiding common technical and diagnostic pitfalls: part 1. J Nucl Med Technol. 2023;51(3):167\u201375.","journal-title":"J Nucl Med Technol"},{"issue":"3","key":"1909_CR56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/8756-3282(95)00216-Z","volume":"17","author":"T Aspray","year":"1995","unstructured":"Aspray T, Prentice A, Cole TJ. The bone mineral content of weight-bearing bones is influenced by the ratio of sitting to standing height in elderly Gambian women. Bone. 1995;17(3):261\u20133.","journal-title":"Bone"},{"issue":"3","key":"1909_CR57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0169-6009(90)90261-D","volume":"10","author":"C Schnitzler","year":"1990","unstructured":"Schnitzler C, et al. Histomorphometry of iliac crest bone in 346 normal black and white South African adults. Bone Miner. 1990;10(3):183\u201399.","journal-title":"Bone Miner"},{"issue":"1","key":"1909_CR58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2012.11.035","volume":"53","author":"JF Baker","year":"2013","unstructured":"Baker JF, et al. Associations between body composition and bone density and structure in men and women across the adult age spectrum. Bone. 2013;53(1):34\u201341.","journal-title":"Bone"},{"key":"1909_CR59","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2015.00024","volume":"6","author":"A Zengin","year":"2015","unstructured":"Zengin A, Prentice A, Ward KA. Ethnic differences in bone health. Front Endocrinol. 2015;6:24.","journal-title":"Front Endocrinol"},{"issue":"3","key":"1909_CR60","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","volume":"56","author":"M Rix","year":"1999","unstructured":"Rix M, et al. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int. 1999;56(3):1084\u201393.","journal-title":"Kidney Int"},{"issue":"1","key":"1909_CR61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11914-005-0021-y","volume":"3","author":"PD Miller","year":"2005","unstructured":"Miller PD. Treatment of osteoporosis in chronic kidney disease and end-stage renal disease. Curr Osteoporos Rep. 2005;3(1):5\u201312.","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"1909_CR62","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s00198-013-2413-7","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, et al. Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporos Int. 2013;24(11):2763\u20134.","journal-title":"Osteoporos Int"},{"key":"1909_CR63","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00198-019-04864-4","volume":"30","author":"K Bezerra de Carvalho","year":"2019","unstructured":"Bezerra de Carvalho K, et al. Chronic kidney disease is associated with low BMD at the hip but not at the spine. Osteoporosis Int. 2019;30:1015\u201323.","journal-title":"Osteoporosis Int"},{"issue":"1","key":"1909_CR64","first-page":"8852690","volume":"2020","author":"J-F Huang","year":"2020","unstructured":"Huang J-F, et al. Association between bone mineral density and severity of chronic kidney disease. International journal of endocrinology. 2020;2020(1):8852690.","journal-title":"International journal of endocrinology"},{"issue":"1","key":"1909_CR65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","volume":"27","author":"S Iimori","year":"2012","unstructured":"Iimori S, et al. Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2014a single-center cohort study. Nephrol Dial Transplant. 2012;27(1):345\u201351.","journal-title":"Nephrol Dial Transplant"},{"key":"1909_CR66","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","volume":"18","author":"J Kanis","year":"2007","unstructured":"Kanis J, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18:1033\u201346.","journal-title":"Osteoporos Int"},{"key":"1909_CR67","volume":"6","author":"B Prasad","year":"2019","unstructured":"Prasad B, et al. Association of bone mineral density with fractures across the spectrum of chronic kidney disease: the Regina CKD-MBD study. Can J Kidney Health Dis. 2019;6:2054358119870539.","journal-title":"Can J Kidney Health Dis"},{"key":"1909_CR68","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11255-010-9723-x","volume":"43","author":"C Ambrus","year":"2011","unstructured":"Ambrus C, et al. Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis. Int Urol Nephrol. 2011;43:475\u201382.","journal-title":"Int Urol Nephrol"},{"key":"1909_CR69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00198-014-2813-3","volume":"26","author":"R Bucur","year":"2015","unstructured":"Bucur R, et al. Low bone mineral density and fractures in stages 3\u20135 CKD: an updated systematic review and meta-analysis. Osteoporos Int. 2015;26:449\u201358.","journal-title":"Osteoporos Int"},{"issue":"6","key":"1909_CR70","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","volume":"92","author":"A Pimentel","year":"2017","unstructured":"Pimentel A, et al. Fractures in patients with CKD\u2014diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation. Kidney Int. 2017;92(6):1343\u201355.","journal-title":"Kidney Int"},{"key":"1909_CR71","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1007\/s00198-012-1908-y","volume":"23","author":"S Jamal","year":"2012","unstructured":"Jamal S, et al. Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease. Osteoporos Int. 2012;23:2805\u201313.","journal-title":"Osteoporos Int"},{"issue":"7","key":"1909_CR72","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","volume":"7","author":"RH Yenchek","year":"2012","unstructured":"Yenchek RH, et al. Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol. 2012;7(7):1130\u20136.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"1909_CR73","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jcem.84.2.5498","volume":"84","author":"Y Duan","year":"1999","unstructured":"Duan Y, De Luca V, Seeman E. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab. 1999;84(2):718\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1909_CR74","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jc.2012-4188","volume":"98","author":"MR Denburg","year":"2013","unstructured":"Denburg MR, et al. Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. J Clin Endocrinol Metab. 2013;98(5):1930\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Supplement_3","key":"1909_CR75","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.2215\/CJN.04151206","volume":"3","author":"B Clarke","year":"2008","unstructured":"Clarke B. Normal bone anatomy and physiology. Clin J Am Soc Nephrol. 2008;3(Supplement_3):S131\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1909_CR76","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/ckj\/sfac034","volume":"15","author":"DA Jaques","year":"2022","unstructured":"Jaques DA, Henderson S, Davenport A. Association between bone mineral density at different anatomical sites and both mortality and fracture risk in patients receiving renal replacement therapy: a longitudinal study. Clin Kidney J. 2022;15(6):1188\u201395.","journal-title":"Clin Kidney J"},{"key":"1909_CR77","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115075","volume":"130","author":"K Iseri","year":"2020","unstructured":"Iseri K, et al. Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: a cohort study. Bone. 2020;130:115075.","journal-title":"Bone"},{"issue":"1","key":"1909_CR78","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.OA.19.00036","volume":"5","author":"S Miyamura","year":"2020","unstructured":"Miyamura S, et al. Utility of distal forearm DXA as a screening tool for primary osteoporotic fragility fractures of the distal radius: a case-control study. JBJS Open Access. 2020;5(1):e0036.","journal-title":"JBJS Open Access"},{"key":"1909_CR79","volume":"15","author":"A Frisoli Jr","year":"2021","unstructured":"Frisoli A Jr, et al. Measuring forearm bone density instead of lumbar spine bone density improves the sensitivity of diagnosing osteoporosis in older adults with cardiovascular diseases: data from SARCOS study. Bone Rep. 2021;15:101134.","journal-title":"Bone Rep"},{"issue":"5","key":"1909_CR80","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02556150","volume":"48","author":"JW Davis","year":"1991","unstructured":"Davis JW, et al. Long-term precision of bone loss rate measurements among postmenopausal women. Calcif Tissue Int. 1991;48(5):311\u20138.","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"1909_CR81","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s001980050249","volume":"10","author":"G Berntsen","year":"1999","unstructured":"Berntsen G, et al. The Troms\u00f8 study: artifacts in forearm bone densitometry\u2013prevalence and effects. Osteoporos Int. 1999;10(5):425\u201332.","journal-title":"Osteoporos Int"},{"issue":"2","key":"1909_CR82","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/2230-8210.109659","volume":"17","author":"M Garg","year":"2013","unstructured":"Garg M, Kharb S. Dual energy X-ray absorptiometry: pitfalls in measurement and interpretation of bone mineral density. Indian J Endocrinol Metab. 2013;17(2):203\u201310.","journal-title":"Indian J Endocrinol Metab"},{"issue":"9","key":"1909_CR83","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10654-008-9271-1","volume":"23","author":"L Fors\u00e9n","year":"2008","unstructured":"Fors\u00e9n L, et al. Differences in precision in bone mineral density measured by SXA and DXA: the NOREPOS study. Eur J Epidemiol. 2008;23(9):615\u201324.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"1909_CR84","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12891-023-06265-5","volume":"24","author":"SB Ma","year":"2023","unstructured":"Ma SB, et al. The clinical necessity of a distal forearm DEXA scan for predicting distal radius fracture in elderly females: a retrospective case-control study. BMC Musculoskelet Disord. 2023;24(1):177.","journal-title":"BMC Musculoskelet Disord"},{"key":"1909_CR85","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-12-818256-7.00004-0","volume-title":"Advanced security and safeguarding in the nuclear power industry","author":"W Martinez-L\u00f3pez","year":"2020","unstructured":"Martinez-L\u00f3pez W, Hande MP. Health effects of exposure to ionizing radiation. In: Advanced security and safeguarding in the nuclear power industry. Hoboken: Elsevier; 2020. p. 81\u201397."},{"issue":"1","key":"1909_CR86","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12891-025-08376-7","volume":"26","author":"MV Papa","year":"2025","unstructured":"Papa MV, et al. The correlation between bone mineral density measured at the forearm and at the lumbar spine or femoral neck: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2025;26(1):151.","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"1909_CR87","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, et al. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467\u201375.","journal-title":"Bone"},{"issue":"4","key":"1909_CR88","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/nep.13826","volume":"26","author":"S Mizuiri","year":"2021","unstructured":"Mizuiri S, et al. Association and predictive value of geriatric nutritional risk index, body composition, or bone mineral density in haemodialysis patients. Nephrology. 2021;26(4):341\u20139.","journal-title":"Nephrology"},{"key":"1909_CR89","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2016.08.007","volume":"92","author":"Z Chen","year":"2016","unstructured":"Chen Z, et al. Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients. Bone. 2016;92:50\u20137.","journal-title":"Bone"},{"issue":"3","key":"1909_CR90","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000126925","volume":"26","author":"K Matsubara","year":"2008","unstructured":"Matsubara K, et al. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality. Blood Purif. 2008;26(3):284\u201390.","journal-title":"Blood Purif"},{"issue":"4","key":"1909_CR91","first-page":"317","volume":"24","author":"PT Goldenstein","year":"2015","unstructured":"Goldenstein PT, Jamal SA, Moys\u00e9s RM. Fractures in chronic kidney disease: pursuing the best screening and management. Curr Opin Nephrol Hypertens. 2015;24(4):317\u201323.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"1909_CR92","doi-asserted-by":"crossref","first-page":"220","DOI":"10.23876\/j.krcp.18.0099","volume":"38","author":"YE Kwon","year":"2019","unstructured":"Kwon YE, et al. Fracture risk in chronic kidney disease: a Korean population-based cohort study. Kidney Res Clin Pract. 2019;38(2):220.","journal-title":"Kidney Res Clin Pract"},{"issue":"1","key":"1909_CR93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3\u201344.","journal-title":"Osteoporos Int"},{"issue":"9","key":"1909_CR94","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a116756","volume":"137","author":"C Cooper","year":"1993","unstructured":"Cooper C, et al. Population-based study of survival after osteoporotic fractures. Am J Epidemiol. 1993;137(9):1001\u20135.","journal-title":"Am J Epidemiol"},{"key":"1909_CR95","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00198-018-4592-8","volume":"29","author":"H Chen","year":"2018","unstructured":"Chen H, et al. Association of renal function with bone mineral density and fracture risk in the Longitudinal Aging Study Amsterdam. Osteoporos Int. 2018;29:2129\u201338.","journal-title":"Osteoporos Int"},{"key":"1909_CR96","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/nep.13457","volume":"23","author":"YC Hou","year":"2018","unstructured":"Hou YC, Lu CL, Lu KC. Mineral bone disorders in chronic kidney disease. Nephrology. 2018;23:88\u201394.","journal-title":"Nephrology"},{"issue":"6","key":"1909_CR97","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7326\/M17-2640","volume":"168","author":"M Ketteler","year":"2018","unstructured":"Ketteler M, et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update. Ann Intern Med. 2018;168(6):422\u201330.","journal-title":"Ann Intern Med"},{"key":"1909_CR98","unstructured":"West SL et al. Retracted: bone mineral density predicts fractures in chronic kidney disease. John Wiley and Sons and The American Society for Bone and Mineral Research; 2015."},{"issue":"4","key":"1909_CR99","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2215\/CJN.06040614","volume":"10","author":"KL Naylor","year":"2015","unstructured":"Naylor KL, et al. Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol. 2015;10(4):646\u201353.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1909_CR100","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00774-016-0788-1","volume":"35","author":"Z Chen","year":"2017","unstructured":"Chen Z, et al. Bone mineral density of extremities is associated with coronary calcification and biopsy-verified vascular calcification in living-donor renal transplant recipients. J Bone Miner Metab. 2017;35(5):536\u201343.","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"1909_CR101","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12882-019-1235-z","volume":"20","author":"Z Chen","year":"2019","unstructured":"Chen Z, et al. Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients. BMC Nephrol. 2019;20(1):59.","journal-title":"BMC Nephrol"},{"issue":"8","key":"1909_CR102","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.3390\/ijms21082685","volume":"21","author":"SJ Lee","year":"2020","unstructured":"Lee SJ, Lee I-K, Jeon J-H. Vascular calcification\u2014new insights into its mechanism. Int J Mol Sci. 2020;21(8):2685.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1909_CR103","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00774-016-0766-7","volume":"35","author":"L Orlic","year":"2017","unstructured":"Orlic L, et al. Forearm bone mass predicts mortality in chronic hemodialysis patients. J Bone Miner Metab. 2017;35(4):396\u2013404.","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"1909_CR104","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, et al. Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int. 2017;92(1):26\u201336.","journal-title":"Kidney Int"},{"issue":"1","key":"1909_CR105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","volume":"36","author":"P Evenepoel","year":"2021","unstructured":"Evenepoel P, et al. European consensus statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4\u2013G5D. Nephrol Dial Transplant. 2021;36(1):42\u201359.","journal-title":"Nephrol Dial Transplant"},{"key":"1909_CR106","doi-asserted-by":"crossref","unstructured":"Gregorini M et al. Understanding bone damage after kidney transplantation: a retrospective monocentric cross sectional analysis. In Transplantation proceedings, Elsevier; 2017.","DOI":"10.1016\/j.transproceed.2017.02.023"},{"issue":"4","key":"1909_CR107","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1399-0012.2008.00810.x","volume":"22","author":"S Dolgos","year":"2008","unstructured":"Dolgos S, et al. Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation. Clin Transplant. 2008;22(4):462\u20138.","journal-title":"Clin Transplant"},{"issue":"8","key":"1909_CR108","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"Kanis JA, et al. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137\u201341.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1909_CR109","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ki.1976.42","volume":"9","author":"HH Malluche","year":"1976","unstructured":"Malluche HH, et al. Bone histology in incipient and advanced renal failure. Kidney Int. 1976;9(4):355\u201362.","journal-title":"Kidney Int"},{"key":"1909_CR110","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00198-014-2982-0","volume":"26","author":"T-M Yu","year":"2015","unstructured":"Yu T-M, et al. Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study. Osteoporos Int. 2015;26:785\u201393.","journal-title":"Osteoporos Int"},{"issue":"2","key":"1909_CR111","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3346\/jkms.2017.32.2.240","volume":"32","author":"CS Kim","year":"2017","unstructured":"Kim CS, et al. Chronic kidney disease-mineral bone disorder in Korean patients: a report from the Korean cohort study for outcomes in patients with chronic kidney disease (KNOW-CKD). J Korean Med Sci. 2017;32(2):240\u20138.","journal-title":"J Korean Med Sci"},{"key":"1909_CR112","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bone.2014.04.017","volume":"64","author":"Z-Z Lin","year":"2014","unstructured":"Lin Z-Z, et al. Epidemiology and mortality of hip fracture among patients on dialysis: Taiwan National Cohort Study. Bone. 2014;64:235\u20139.","journal-title":"Bone"},{"issue":"5","key":"1909_CR113","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000369039","volume":"40","author":"AT Mathew","year":"2014","unstructured":"Mathew AT, et al. Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysis. Am J Nephrol. 2014;40(5):451\u20137.","journal-title":"Am J Nephrol"},{"issue":"5","key":"1909_CR114","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00198-014-2632-6","volume":"25","author":"Y-J Chen","year":"2014","unstructured":"Chen Y-J, et al. Greater risk of hip fracture in hemodialysis than in peritoneal dialysis. Osteoporos Int. 2014;25(5):1513\u20138.","journal-title":"Osteoporos Int"},{"key":"1909_CR115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115242","volume":"133","author":"K Iseri","year":"2020","unstructured":"Iseri K, et al. Major fractures after initiation of dialysis: incidence, predictors and association with mortality. Bone. 2020;133:115242.","journal-title":"Bone"},{"issue":"2","key":"1909_CR116","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00774-020-01144-8","volume":"39","author":"K Iseri","year":"2021","unstructured":"Iseri K, et al. Sparing effect of peritoneal dialysis vs hemodialysis on BMD changes and its impact on mortality. J Bone Miner Metab. 2021;39(2):260\u20139.","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"1909_CR117","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00198-014-2813-3","volume":"26","author":"R Bucur","year":"2015","unstructured":"Bucur R, et al. Low bone mineral density and fractures in stages 3\u20135 CKD: an updated systematic review and meta-analysis. Osteoporos Int. 2015;26(2):449\u201358.","journal-title":"Osteoporos Int"},{"key":"1909_CR118","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bone.2015.07.015","volume":"81","author":"Y Iwasaki","year":"2015","unstructured":"Iwasaki Y, et al. Altered material properties are responsible for bone fragility in rats with chronic kidney injury. Bone. 2015;81:247\u201354.","journal-title":"Bone"},{"key":"1909_CR119","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","volume":"100","author":"KA Hruska","year":"2017","unstructured":"Hruska KA, et al. The chronic kidney disease\u2014Mineral bone disorder (CKD-MBD): advances in pathophysiology. Bone. 2017;100:80\u20136.","journal-title":"Bone"},{"key":"1909_CR120","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S97637","author":"C Friedl","year":"2017","unstructured":"Friedl C, Zitt E. Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Int J Nephrol Renovasc Dis. 2017. https:\/\/doi.org\/10.2147\/IJNRD.S97637.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"1","key":"1909_CR121","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.ajkd.2011.12.035","volume":"60","author":"SU Nigwekar","year":"2012","unstructured":"Nigwekar SU, Bhan I, Thadhani R. Ergocalciferol and cholecalciferol in CKD. Am J Kidney Dis. 2012;60(1):139\u201356.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"1909_CR122","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s40620-017-0430-x","volume":"30","author":"P Lips","year":"2017","unstructured":"Lips P, Goldsmith D, de Jongh R. Vitamin D and osteoporosis in chronic kidney disease. J Nephrol. 2017;30(5):671\u20135.","journal-title":"J Nephrol"},{"issue":"5","key":"1909_CR123","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","volume":"24","author":"EA Gonz\u00e1lez","year":"2004","unstructured":"Gonz\u00e1lez EA, et al. Vitamin D Insufficiency and Deficiency in Chronic Kidney DiseaseA Single Center Observational Study. Am J Nephrol. 2004;24(5):503\u201310.","journal-title":"Am J Nephrol"},{"key":"1909_CR124","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00198-009-1142-4","volume":"21","author":"P Manghat","year":"2010","unstructured":"Manghat P, et al. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease. Osteoporos Int. 2010;21:1853\u201361.","journal-title":"Osteoporos Int"},{"key":"1909_CR125","first-page":"73","volume":"2","author":"HM Frost","year":"1987","unstructured":"Frost HM. The mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and non mechanical agents. Bone Miner. 1987;2:73\u201385.","journal-title":"Bone Miner"},{"key":"1909_CR126","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1007\/s00198-013-2378-6","volume":"24","author":"S-G Lee","year":"2013","unstructured":"Lee S-G, et al. Additive association of vitamin D insufficiency and sarcopenia with low femoral bone mineral density in noninstitutionalized elderly population: the Korea National Health and Nutrition Examination Surveys 2009\u20132010. Osteoporos Int. 2013;24:2789\u201399.","journal-title":"Osteoporos Int"},{"issue":"5","key":"1909_CR127","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40620-017-0404-z","volume":"30","author":"J Bover","year":"2017","unstructured":"Bover J, et al. Osteoporosis, bone mineral density and CKD\u2013MBD: treatment considerations. J Nephrol. 2017;30(5):677\u201387.","journal-title":"J Nephrol"},{"issue":"4","key":"1909_CR128","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/nu9040328","volume":"9","author":"G Jean","year":"2017","unstructured":"Jean G, Souberbielle JC, Chazot C. Vitamin D in chronic kidney disease and dialysis patients. Nutrients. 2017;9(4):328.","journal-title":"Nutrients"},{"key":"1909_CR129","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cca.2019.11.010","volume":"501","author":"I Capelli","year":"2020","unstructured":"Capelli I, et al. Nutritional vitamin D in CKD: should we measure? Should we treat? Clin Chim Acta. 2020;501:186\u201397.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"1909_CR130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.ajkd.2014.04.020","volume":"64","author":"A Massart","year":"2014","unstructured":"Massart A, et al. Biochemical parameters after cholecalciferol repletion in hemodialysis: results from the VitaDial randomized trial. Am J Kidney Dis. 2014;64(5):696\u2013705.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1909_CR131","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/nu10020196","volume":"10","author":"C-M Zheng","year":"2018","unstructured":"Zheng C-M, et al. Cholecalciferol additively reduces serum parathyroid hormone levels in severe secondary hyperparathyroidism treated with calcitriol and cinacalcet among hemodialysis patients. Nutrients. 2018;10(2):196.","journal-title":"Nutrients"},{"issue":"5","key":"1909_CR132","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1053\/j.ajkd.2023.04.003","volume":"82","author":"W-CG Yeung","year":"2023","unstructured":"Yeung W-CG, et al. Vitamin D therapy in adults with CKD: a systematic review and meta-analysis. Am J Kidney Dis. 2023;82(5):543\u201358.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1909_CR133","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ndt\/gfae293","volume":"40","author":"HS J\u00f8rgensen","year":"2025","unstructured":"J\u00f8rgensen HS, et al. The role of nutritional vitamin D in chronic kidney disease\u2013mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation\u2014a European consensus statement. Nephrol Dial Transplant. 2025;40(4):797\u2013822.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"1909_CR134","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/jbmr.4913","volume":"38","author":"H Komaba","year":"2023","unstructured":"Komaba H, et al. Active vitamin D use and fractures in hemodialysis patients: results from the international DOPPS. J Bone Miner Res. 2023;38(11):1577\u201385.","journal-title":"J Bone Miner Res"},{"key":"1909_CR135","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global","year":"2009","unstructured":"Kidney Disease: Improving Global. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. 2009;113:S1-s130.","journal-title":"Kidney Int"},{"issue":"1","key":"1909_CR136","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40620-015-0196-y","volume":"29","author":"P Delanaye","year":"2016","unstructured":"Delanaye P, et al. Efficiency of delivery observed treatment in hemodialysis patients: the example of the native vitamin D therapy. J Nephrol. 2016;29(1):99\u2013103.","journal-title":"J Nephrol"},{"issue":"5","key":"1909_CR137","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1523-1755.2000.00394.x","volume":"58","author":"CO Stehman-Breen","year":"2000","unstructured":"Stehman-Breen CO, et al. Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int. 2000;58(5):2200\u20135.","journal-title":"Kidney Int"},{"issue":"1","key":"1909_CR138","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13098-024-01440-7","volume":"16","author":"M Martiniakova","year":"2024","unstructured":"Martiniakova M, et al. Interrelationships among metabolic syndrome, bone-derived cytokines, and the most common metabolic syndrome-related diseases negatively affecting bone quality. Diabetol Metab Syndr. 2024;16(1):217.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"1909_CR139","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12905-022-01662-9","volume":"22","author":"Y Yang","year":"2022","unstructured":"Yang Y, Wang S, Cong H. Association between parity and bone mineral density in postmenopausal women. BMC Womens Health. 2022;22(1):87.","journal-title":"BMC Womens Health"},{"issue":"7","key":"1909_CR140","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1359\/jbmr.2002.17.7.1273","volume":"17","author":"FE McGuigan","year":"2002","unstructured":"McGuigan FE, et al. Genetic and environmental determinants of peak bone mass in young men and women. J Bone Miner Res. 2002;17(7):1273\u20139.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"1909_CR141","first-page":"2435","volume":"51","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. Prevalence and distribution of osteopenia in Chinese population: a system review and meta-analysis. Iran J Public Health. 2022;51(11):2435.","journal-title":"Iran J Public Health"},{"key":"1909_CR142","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bone.2018.06.004","volume":"114","author":"K Trajanoska","year":"2018","unstructured":"Trajanoska K, et al. Fracture incidence and secular trends between 1989 and 2013 in a population based cohort: the Rotterdam Study. Bone. 2018;114:116\u201324.","journal-title":"Bone"},{"issue":"8","key":"1909_CR143","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3390\/nu10081103","volume":"10","author":"D Agostini","year":"2018","unstructured":"Agostini D, et al. Muscle and bone health in postmenopausal women: role of protein and vitamin D supplementation combined with exercise training. Nutrients. 2018;10(8):1103.","journal-title":"Nutrients"},{"issue":"4","key":"1909_CR144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251035","volume":"16","author":"A Velioglu","year":"2021","unstructured":"Velioglu A, et al. Low bone density, vertebral fracture and FRAX score in kidney transplant recipients: a cross-sectional cohort study. PLoS ONE. 2021;16(4):e0251035.","journal-title":"PLoS ONE"},{"issue":"10","key":"1909_CR145","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s00198-022-06454-3","volume":"33","author":"P-L Xiao","year":"2022","unstructured":"Xiao P-L, et al. Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis. Osteoporos Int. 2022;33(10):2137\u201353.","journal-title":"Osteoporos Int"},{"issue":"4","key":"1909_CR146","first-page":"335","volume":"38","author":"O Adejumo","year":"2021","unstructured":"Adejumo O, et al. Self-perceived burden on caregivers, anxiety and depression among chronic kidney disease patients in Southern Nigeria. West Afr J Med. 2021;38(4):335\u201341.","journal-title":"West Afr J Med"},{"issue":"1","key":"1909_CR147","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/ipj.ipj_23_19","volume":"28","author":"WA Khan","year":"2019","unstructured":"Khan WA, et al. A comparative study of psychosocial determinants and mental well-being in chronic kidney disease patients: a closer look. Ind Psychiatry J. 2019;28(1):63\u20137.","journal-title":"Ind Psychiatry J"},{"issue":"19","key":"1909_CR148","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1001\/jama.2010.619","volume":"303","author":"SS Hedayati","year":"2010","unstructured":"Hedayati SS, et al. Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA. 2010;303(19):1946\u201353.","journal-title":"JAMA"},{"issue":"1","key":"1909_CR149","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/ajkd.2003.50029","volume":"41","author":"S Watnick","year":"2003","unstructured":"Watnick S, et al. The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis. 2003;41(1):105\u201310.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1909_CR150","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0020-7489(01)00030-X","volume":"39","author":"S-L Tsay","year":"2002","unstructured":"Tsay S-L, Healstead M. Self-care self-efficacy, depression, and quality of life among patients receiving hemodialysis in Taiwan. Int J Nurs Stud. 2002;39(3):245\u201351.","journal-title":"Int J Nurs Stud"},{"issue":"1","key":"1909_CR151","doi-asserted-by":"crossref","first-page":"c35","DOI":"10.1159\/000286348","volume":"115","author":"GB Lopes","year":"2010","unstructured":"Lopes GB, et al. Depression as a potential explanation for gender differences in health-related quality of life among patients on maintenance hemodialysis. Nephron Clin Pract. 2010;115(1):c35\u201340.","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"1909_CR152","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejim.2009.03.007","volume":"20","author":"SA Tavallaii","year":"2009","unstructured":"Tavallaii SA, et al. Effect of depression on health care utilization in patients with end-stage renal disease treated with hemodialysis. Eur J Intern Med. 2009;20(4):411\u20134.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"1909_CR153","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000289029","volume":"65","author":"T Sensky","year":"1996","unstructured":"Sensky T, Leger C, Gilmour S. Psychosocial and cognitive factors associated with adherence to dietary and fluid restriction regimens by people on chronic haemodialysis. Psychother Psychosom. 1996;65(1):36\u201342.","journal-title":"Psychother Psychosom"},{"issue":"9","key":"1909_CR154","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s40620-024-01998-5","volume":"37","author":"OA Adejumo","year":"2024","unstructured":"Adejumo OA, et al. Global prevalence of depression in chronic kidney disease: a systematic review and meta-analysis. J Nephrol. 2024;37(9):2455\u201372.","journal-title":"J Nephrol"},{"key":"1909_CR155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00774-005-0650-3","volume":"24","author":"FF Ersoy","year":"2006","unstructured":"Ersoy FF, et al. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab. 2006;24:79\u201386.","journal-title":"J Bone Miner Metab"},{"issue":"5","key":"1909_CR156","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/JSM.0b013e31825d5d65","volume":"22","author":"BS Lambert","year":"2012","unstructured":"Lambert BS, et al. DEXA or BMI: clinical considerations for evaluating obesity in collegiate division IA American football athletes. Clin J Sport Med. 2012;22(5):436\u20138.","journal-title":"Clin J Sport Med"},{"key":"1909_CR157","doi-asserted-by":"crossref","unstructured":"Mounach A et al. Discordance between hip and spine bone mineral density measurement using DXA: prevalence and risk factors. In: Seminars in arthritis and rheumatism. Elsevier; 2009.","DOI":"10.1016\/j.semarthrit.2008.04.001"},{"issue":"9","key":"1909_CR158","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.acra.2020.07.028","volume":"28","author":"D Albano","year":"2021","unstructured":"Albano D, et al. Operator-related errors and pitfalls in dual energy X-ray absorptiometry: how to recognize and avoid them. Acad Radiol. 2021;28(9):1272\u201386.","journal-title":"Acad Radiol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01909-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01909-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01909-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:47:42Z","timestamp":1764917262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01909-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":158,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1909"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01909-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"An ethical declaration is unnecessary for this research since it relies on a systematic review and meta-analysis of previously published literature, and the study was conducted in accordance with the PRIMSMA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"362"}}